Atypical hemolytic-uremic syndrome: genes and variants

Explore variant evidence for Atypical hemolytic-uremic syndrome across 4 analyzed proteins (CFH, C3, HBB, C5). Linked ClinVar records include 18 pathogenic or likely pathogenic variants, 73 variants of uncertain significance and 16 with conflicting classifications.

Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.

Data updated 2026-11-05. Automated aggregation, not a clinical review date.

Download variant evidence (CSV)

Genes linked to Atypical hemolytic-uremic syndrome

Weakly linked (only a few uncertain records): COL4A4, ADAMTS13, COL4A3, COL4A5 and NPHS1.

Where Atypical hemolytic-uremic syndrome variants cluster

ClinVar pathogenic and likely pathogenic variants linked to Atypical hemolytic-uremic syndrome

VariantPositionProtein partClinical label
CFH W1183L1183Sushi 20Pathogenic / likely pathogenic (★★)
C3 R592W592Pathogenic / likely pathogenic (★★)
C3 R592Q592Pathogenic / likely pathogenic (★★)
CFH P1226S1226Sushi 20Pathogenic / likely pathogenic (★★)
CFH D1119G1119Sushi 19Pathogenic / likely pathogenic (★★)
C3 I1157T1157Pathogenic / likely pathogenic (★★)
CFH W1183R1183Sushi 20Pathogenic / likely pathogenic (★)
C3 G1116R1116Pathogenic / likely pathogenic (★)
CFH C431S431Sushi 7Pathogenic / likely pathogenic (★)
CFH C325Y325Sushi 6Pathogenic / likely pathogenic (★)
CFH C673Y673Sushi 11Pathogenic / likely pathogenic (★)
CFH W978C978Sushi 16Pathogenic / likely pathogenic (★)
CFH W1157R1157Sushi 19Pathogenic / likely pathogenic (★)
CFH C1163W1163Sushi 19Pathogenic / likely pathogenic (★)
CFH R1215G1215Sushi 20Pathogenic / likely pathogenic (★)
HBB L69P69GlobinPathogenic / likely pathogenic (★)
C3 A1094V1094Pathogenic / likely pathogenic (★)
CFH Y1021F1021Sushi 17Pathogenic / likely pathogenic (★)

Uncertain variants prioritized for review in Atypical hemolytic-uremic syndrome

VariantPositionProtein partClinical labelEvidence
CFH W1183C1183Sushi 20Uncertain (★)+6: 2 other pathogenic changes within 3 positions; W1183L at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.98

Which prediction tools work for Atypical hemolytic-uremic syndrome

Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.

Same protein, different disease

Diseases related to Atypical hemolytic-uremic syndrome

Frequently asked questions

Which genes have records linked to Atypical hemolytic-uremic syndrome?

This view contains 4 analyzed proteins: CFH, C3, HBB, C5. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.

What do the clinical classifications mean?

Linked records include 18 pathogenic or likely pathogenic variants, 73 variants of uncertain significance and 16 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.

Does the evidence score change a VUS classification?

No. 1 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.

Can I download the variant evidence?

Download the CSV for all 133 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.

About this data

Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.

Download every variant as CSV · Browse all diseases · Methods · About the Center